Patent Assignment
Reel/Frame 067680/0770
Assignment of Assignor's Interest
Recorded: 2024-06-10
Pages: 61
Assignor
INHIBRX, INC.
Executed: 2024-05-28
Assignee
INHIBRX BIOSCIENCES, INC.
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(22)
CD47 Antibodies and Methods of Use Thereof
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
13/960,136 →
Publication:
US 2014/0140989
CD47 Antibodies and Methods of Use Thereof
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
14/841,619 →
Publication:
US 2016/0251435
Non-Immunogenic Single Domain Antibodies
Multispecific Gitr-Binding Fusion Proteins and Methods of Use Thereof
Multivalent and Multispecific Gitr-Binding Fusion Proteins
Application:
15/618,922 →
Publication:
US 2017/0320958
Multivalent and Multispecific Glucocorticoid-Induced Tnfr-Related Protein (Gitr)-Binding Single-Domain Antibody Fusion Proteins and Encoding Nucleic Acids
Non-Immunogenic Single Domain Antibodies
Application:
16/685,087 →
Publication:
US 2020/0140525
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
17/170,854 →
Publication:
US 2021/0317205
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
Siglec-8 Binding Proteins and Uses Thereof
Application:
18/361,184 →
Publication:
US 2023/0406925
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
18/451,025 →
Publication:
US 2024/0166744
Anti-CD47 Antibodies and Methods of Use Thereof
Application:
61/595,216 →
Anti-CD47 Antibodies and Methods of Use Thereof
Application:
61/659,752 →
CD47 Antibodies and Methods of Use Thereof
Application:
61/815,219 →
Non-Immunogenic Single Domain Antibodies
Application:
62/106,035 →
Multivalent and Multispecific Gitr-Binding Fusion Proteins
Application:
62/195,822 →
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application:
62/744,638 →
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application:
62/832,265 →
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application:
62/877,815 →
Siglec-8 Binding Polypeptides and Uses Thereof
Application:
63/333,952 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 12, 2012
From: DEVERAUX, QUINN; ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR
To: INHIBRX LLC
Reel/Frame 028357/0966 →
Assignment of Assignor's Interest
Jun 15, 2012
From: ECKELMAN, BRENDAN; TIMMER, JOHN; JONES, KYLE; RAZAI, AMIR
To: INHIBRX LLC
Reel/Frame 028383/0510 →
Assignment of Assignor's Interest
Jul 10, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 030766/0522 →
Assignment of Assignor's Interest
Aug 23, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 031067/0456 →
Assignment of Assignor's Interest
Aug 14, 2014
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX, LLC
Reel/Frame 033539/0219 →
Assignment of Assignor's Interest
Jul 2, 2015
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX BIOPHARMA, LLC
Reel/Frame 035974/0879 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 035974 Frame: 0879. Assignor(S) Hereby Confirms the Assignment.
Jul 7, 2015
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX BIOPHARMA LLC
Reel/Frame 036074/0533 →
Assignment of Assignor's Interest
Sep 15, 2015
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 036571/0681 →
Assignment of Assignor's Interest
Oct 26, 2015
From: TIMMER, JOHN C.; JONES, KYLE S.; RAZAI, AMIR S.; HUSSAIN, ABRAHIM
To: INHIBRX LP
Reel/Frame 036879/0545 →
Assignment of Assignor's Interest
Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 038281/0055 →
Change of Name
May 11, 2016
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 038685/0028 →
Assignment of Assignor's Interest
May 11, 2016
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX, LLC
Reel/Frame 038554/0506 →
Change of Name
Aug 25, 2016
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 039738/0543 →
Assignment of Assignor's Interest
Sep 29, 2016
From: TIMMER, JOHN C.; JONES, KYLE S.; RAZAI, AMIR S.; HUSSAIN, ABRAHIM
To: INHIBRX LP
Reel/Frame 039893/0449 →
Corrective Assignment to Correct the Assignor Field from Katelyn M. Wills to Katelyn M. Willis Previously Recorded on Reel 039893 Frame 0449. Assignor(S) Hereby Confirms the Assignment for the Listed Properties.
Nov 21, 2016
From: WILLIS, KATELYN M.
To: INHIBRX LP
Reel/Frame 041349/0367 →
Assignment of Assignor's Interest
Jun 12, 2017
From: TIMMER, JOHN C.; JONES, KYLE S.; RAZAI, AMIR S.; HUSSAIN, ABRAHIM
To: INHIBRX LP
Reel/Frame 042674/0112 →
Assignment of Assignor's Interest
Nov 15, 2017
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX LP
Reel/Frame 044133/0835 →
Merger and Change of Name
May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Merger and Change of Name
May 23, 2018
From: INHIBRX, LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046216/0820 →
Corrective Assignment to Correct the Receiving Party Address Change Previously Recorded at Reel: 046216 Frame: 0820. Assignor(S) Hereby Confirms the Assignment.
Jul 2, 2018
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 046635/0320 →
Assignment of Assignor's Interest
Feb 5, 2019
From: ECKELMAN, BRENDAN P.; KAPLAN, MICHAEL D.; WILLIS, KATELYN M.; PANDIT, RAJAY A.
To: INHIBRX, INC.
Reel/Frame 048238/0369 →
Assignment of Assignor's Interest
Jul 9, 2019
From: ECKELMAN, BRENDAN P.; KAPLAN, MICHAEL D.; WILLIS, KATELYN M.; PANDIT, RAJAY A.
To: INHIBRX, INC.
Reel/Frame 049705/0269 →
Assignment of Assignor's Interest
Sep 6, 2019
From: ECKELMAN, BRENDAN P.; KAPLAN, MICHAEL D.; WILLIS, KATELYN M.; PANDIT, RAJAY A.
To: INHIBRX, INC.
Reel/Frame 050298/0788 →
Merger
Oct 25, 2019
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 050890/0760 →
Change of Name
Oct 25, 2019
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 050832/0610 →